MammoScreen automatically detects and characterizes suspicious soft-tissue lesions and calcifications on mammography exams, according to the vendor. It then provides a summary report that characterizes the likelihood of malignancy for each lesion with a score from 1 (least likely) to 10 (most likely).

The company said that a multireader, multicase study conducted last year showed that readers using MammoScreen detected more cancers on mammograms than radiologists who did not have access to the software.